-
Mashup Score: 3
Laparoscopy may reduce the degree of pain or length of hospital stay compared with open surgery for patients with colorectal cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Cancer Network - 6 day(s) ago
Cancer Network job board. Connecting the best jobs with top talent.
Source: cancer-network.myjboard.ioCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The primary end point of overall survival was met in the KEYNOTE-811 trial assessing pembrolizumab in HER2-positive gastrointestinal cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17
Tisotumab vedotin-tftv may now be given to patients with recurrent or metastatic cervical cancer, according to the FDA.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1USPSTF Recommends Breast Cancer Screening Starting at Age 40 - 7 day(s) ago
Biennial screening mammography is recommended for those who are 40 to 74 years old rather than individualizing screening decisions in this age group.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Conference - 7 day(s) ago
Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Treatment with cilta-cel may give patients with multiple myeloma “more time,” according to Ishmael Applewhite, BSN, RN-BC, OCN.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1USPSTF Recommends Breast Cancer Screening Starting at Age 40 - 8 day(s) ago
Biennial screening mammography is recommended for those who are 40 to 74 years old rather than individualizing screening decisions in this age group.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Findings from the CheckMate-901 trial support the CHMP’s positive opinion of nivolumab plus chemotherapy in metastatic urothelial carcinoma.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Safety findings highlight no severe adverse effects or dose-limiting toxicities with the rintatolimod combination in late-stage pancreatic cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
View our top 5 articles of the week:@JTCancerCenter @US_FDA @FDAOncology @OmidHamidMD @TOSHI_Iwase 1. https://t.co/w57J86FkXx 2. https://t.co/1RmwSP7FzF 3. https://t.co/cjBKEDHvBD 4. https://t.co/eIYbLeLAiv 5. https://t.co/k9qWysY97C https://t.co/G8MnazIc9X